Clinical trial
Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection
NCT05460403 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection
- Lead sponsor
- Chinese Academy of Medical Sciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 23, 2022
- Completion date
- August 31, 2023
- Enrollment
- 3,591 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
esophageal cancer